In conclusion, we reveal an immunoregulatory circuit in which AKG inhibited RCC tumor growth by attenuating the enrichment of H3K4me1 in the promoter regions to upregulate B2M expression and enhance CD8+ T cell‐mediated anti‐tumor immunity. This evidence concerns the gene CD8A and renal cell carcinoma.